After initial setback, IL-12 regaining popularity

Journal of the National Cancer Institute

Volumn 88, Issue 9, 1996, Pages 576-577

  Jenks, S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

BREAST CANCER; CELLULAR IMMUNITY; CLINICAL TRIAL; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; GENE THERAPY; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; MELANOMA; MEMORY CELL; NOTE;

DRUG ADMINISTRATION SCHEDULE; GENE THERAPY; HUMANS; INTERLEUKIN-12; KIDNEY NEOPLASMS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0030005001     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.9.576     Document Type: Note

References (0)